About this trial
This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients
aged 18 years or older
Diagnosis of a gynecologic cancer
Receiving care at the participating institution
Disqualifiers
Inability to access or complete the online questionnaire or difficulty with reading and writing
Cognitive impairment
Patients currently hospitalized or in emergency settings.
Trial population
Patients with gynecologic cancers receiving care at the participating institution who are invited to complete an anonymous online survey assessing their interest in a nighttime Day Hospital service for long-duration chemotherapy infusions.
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
online survey
BehavioralParticipants will complete an anonymous online survey designed to assess their interest in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions.
Treatment groups
Trial outcomes
Primary outcomes
Level of patient interest in a nighttime Day Hospital service for long-duration chemotherapy infusions
Assessment of the level of interest among patients with gynecologic cancers in receiving long-duration chemotherapy infusions during nighttime hours in a Day Hospital setting, as evaluated through responses to an anonymous online survey.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: